Not just the ethical process but the scientific and other issues should be modified and improve in order to develop better strategies in stem cell translational research. However, we have to look into more simple and effective process that protect the patients autonomy but also that promotes progression to help them.
At the 4th International Conference on Tissue Science and Regenerative Medicine held in Rome at the end of July, the team of the ASRM was able to present state-of-the-art research titled: “Neuron point of care stem cell therapy: Intrathecal transplant of autologous bone marrow-derived stem...
Our findings support a paracrine mechanism by which i.t. BMSCs target CXCL12-producing DRGs to elicit neuroprotection and sustained neuropathic pain relief via TGF-β1 secretion. Conclude Chen et al.
Three-dimensional neural cultures (organoids) derived from induced pluripotent stem cells (iPSCs) to investigate neurodevelopmental alterations in individuals with severe idiopathic ASD.
At the annual meeting of the ISSCR in Stockholm, members of our society presented one of our scientific publications: “Statistical relationship between levels of autologous bone marrow-derived CD34+ and clinical status of patients with amyotrophic lateral...
"We conclude that both reprogramming approaches offer complementary strategies for derivation of PSCs containing exclusively wild-type mtDNA, through spontaneous segregation of heteroplasmic mtDNA in individual iPS cell lines or mitochondrial replacement by SCNT in homoplasmic mtDNA-based disease." Hong Ma. et al.
A scientific group at the University of Bristol discovered that the migration defects of fibroblasts from human venous leg ulcer patients can be reversed by ultrasound, demonstrating that the approach is applicable to human chronic samples.
This interesting finding supports also some of the cell therapies...
Increased cerebral infiltration of monocytes, either by enrichment of their levels in the circulation or by weekly immunization with glatiramer acetate,...
A suitable clinical strategy for Regenerative Medicine.
EnSCs derived from menstrual blood, as autologous stem cells, may restore damaged ovarian function and offer a suitable clinical strategy for Regenerative Medicine.
A new study lead by Professor Pessequé in the Center of Regeneration at UCSF identified a family of cells called multipotent progenitors (MPPs). This cells are...